Guideline-concordant antimicrobial therapy for healthcare-associated pneumonia: A systematic review and meta-analysis

Lung

Volumn 191, Issue 3, 2013, Pages 229-237

  Troitino, Anthony X ^a   Porhomayon, Jahan ^a   El Solh, Ali A ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

Antibiotics; Guidelines; Healthcare associated pneumonia; Outcome

Indexed keywords

ANTIMICROBIAL THERAPY; CONFIDENCE INTERVAL; GENETIC HETEROGENEITY; HEALTHCARE ASSOCIATED INFECTION; HOSPITALIZATION; HUMAN; LENGTH OF STAY; META ANALYSIS; MORTALITY; OUTCOME ASSESSMENT; PNEUMONIA; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SYSTEMATIC REVIEW;

ANTI-INFECTIVE AGENTS; CROSS INFECTION; GUIDELINE ADHERENCE; HUMANS; LENGTH OF STAY; ODDS RATIO; PNEUMONIA; PRACTICE GUIDELINES AS TOPIC; TIME FACTORS; TREATMENT OUTCOME;

EID: 84878744362     PISSN: 03412040     EISSN: 14321750     Source Type: Journal    
DOI: 10.1007/s00408-013-9462-8     Document Type: Review

References (42)

1. American Thoracic Society, Infectious Diseases Society of America (2005) Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 171(4):388-416
2. Centers for Disease Control and Prevention, Jajosky RA, Hall PA, Adams DA, Dawkins FJ, Sharp P, Anderson WJ, Aponte JJ, Jones GF, Nitschke DA, Worsham CA, Adekoya N, Doyle T (2006) Summary of notifiable diseases-United States, 2004. MMWR Morb Mortal Wkly Rep 53(53):1-79
3. Carratala J, Garcia-Vidal C (2008) What is healthcare-associated pneumonia and how is it managed? Curr Opin Infect Dis 21(2):168-173
4. Venditti M, Falcone M, Corrao S, Licata G, Serra P, Study Group of the Italian Society of Internal Medicine (2009) Outcomes of patients hospitalized with community-acquired, health care-associated, and hospital-acquired pneumonia. Ann Intern Med 150(1):19-26
5. Cecere LM, Rubenfeld GD, Park DR, Root RK, Goss CH (2010) Long-term survival after hospitalization for community-acquired and healthcare-associated pneumonia. Respiration 79(2):128-136
6. Kollef MH, Shorr A, Tabak YP, Gupta V, Liu LZ, Johannes RS (2005) Epidemiology and outcomes of health-care-associated pneumonia: results from a large US database of culture-positive pneumonia. Chest 128(6):3854-3862
7. Micek ST, Kollef KE, Reichley RM, Roubinian N, Kollef MH (2007) Health care-associated pneumonia and community-acquired pneumonia: a single-center experience. Antimicrob Agents Chemother 51(10):3568-3573
8. Zilberberg MD, Shorr AF, Micek ST, Mody SH, Kollef MH (2008) Antimicrobial therapy escalation and hospital mortality among patients with health-care-associated pneumonia: a single-center experience. Chest 134(5):963-968
9. Ewig S, Welte T (2012) Adding fuel to the flames? It is time to leave HCAP. Respir Med 106(9):1309-1310
10. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB (2000) Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 283(15):2008-2012
11. Downs SH, Black N (1998) The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. J Epidemiol Community Health 52(6):377-384
12. Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327(7414):557-560
13. Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315(7109):629-634
14. Ioannidis JP, Trikalinos TA (2005) Early extreme contradictory estimates may appear in published research: the Proteus phenomenon in molecular genetics research and randomized trials. J Clin Epidemiol 58(6):543-549
15. Garcia-Vidal C, Viasus D, Roset A, Adamuz J, Verdaguer R, Dorca J, Gudiol F, Carratala J (2011) Low incidence of multidrug-resistant organisms in patients with healthcare-associated pneumonia requiring hospitalization. Clin Microbiol Infect 17(11):1659-1665
16. Madaras-Kelly KJ, Remington RE, Sloan KL, Fan VS (2012) Guideline-based antibiotics and mortality in healthcare-associated pneumonia. J Gen Intern Med 27(7):845-852
17. El Solh AA, Akinnusi ME, Alfarah Z, Patel A (2009) Effect of antibiotic guidelines on outcomes of hospitalized patients with nursing home-acquired pneumonia. J Am Geriatr Soc 57(6):1030-1035
18. Attridge RT, Frei CR, Restrepo MI, Lawson KA, Ryan L, Pugh MJ, Anzueto A, Mortensen EM (2011) Guideline-concordant therapy and outcomes in healthcare-associated pneumonia. Eur Respir J 38(4):878-887
19. Grenier C, Pepin J, Nault V, Howson J, Fournier X, Poirier MS, Cabana J, Craig C, Beaudoin M, Valiquette L (2011) Impact of guideline-consistent therapy on outcome of patients with healthcare-associated and community-acquired pneumonia. J Antimicrob Chemother 66(7):1617-1624
20. Falcone M, Corrao S, Licata G, Serra P, Venditti M (2012) Clinical impact of broad-spectrum empirical antibiotic therapy in patients with healthcare-associated pneumonia: a multicenter interventional study. Intern Emerg Med 7(6):523-531
21. Taylor SP, Taylor BT (2013) Healthcare-associated pneumonia in hemodialysis patients: clinical outcomes in patients treated with narrow versus broad spectrum antibiotic therapy. Respirology 18:364-368
22. Webb BJ, Dangerfield BS, Pasha JS, Agrwal N, Vikram HR (2012) Guideline-concordant antibiotic therapy and clinical outcomes in healthcare-associated pneumonia. Respir Med 106(11):1606-1612
23. Mortensen EM, Coley CM, Singer DE, Marrie TJ, Obrosky DS, Kapoor WN, Fine MJ (2002) Causes of death for patients with community-acquired pneumonia: results from the pneumonia patient outcomes research team cohort study. Arch Intern Med 162(9):1059-1064
24. Menendez R, Torres A, Zalacain R, Aspa J, Martin-Villasclaras JJ, Borderias L, Benitez-Moya JM, Ruiz-Manzano J, de Castro FR, Blanquer J, Perez D, Puzo C, Sanchez-Gascon F, Gallardo J, Alvarez C, Molinos L, Group N (2005) Guidelines for the treatment of community-acquired pneumonia: predictors of adherence and outcome. Am J Respir Crit Care Med 172(6):757-762
25. Frei CR, Attridge RT, Mortensen EM, Restrepo MI, Yu Y, Oramasionwu CU, Ruiz JL, Burgess DS (2010) Guideline-concordant antibiotic use and survival among patients with community-acquired pneumonia admitted to the intensive care unit. Clin Ther 32(2):293-299
26. Mortensen EM, Restrepo M, Anzueto A, Pugh J (2004) Effects of guideline-concordant antimicrobial therapy on mortality among patients with community-acquired pneumonia. Am J Med 117(10):726-731
27. Frei CR, Restrepo MI, Mortensen EM, Burgess DS (2006) Impact of guideline-concordant empiric antibiotic therapy in community-acquired pneumonia. Am J Med 119(10):865-871
28. McCabe C, Kirchner C, Zhang H, Daley J, Fisman DN (2009) Guideline-concordant therapy and reduced mortality and length of stay in adults with community-acquired pneumonia: playing by the rules. Arch Intern Med 169(16):1525-1531
29. Wu JH, Howard DH, McGowan JE Jr, Turpin RS, Henry Hu X (2006) Adherence to Infectious Diseases Society of America guidelines for empiric therapy for patients with community-acquired pneumonia in a commercially insured cohort. Clin Ther 28(9):1451-1461
30. Dean NC, Bateman KA, Donnelly SM, Silver MP, Snow GL, Hale D (2006) Improved clinical outcomes with utilization of a community-acquired pneumonia guideline. Chest 130(3):794-799
31. Chalmers JD, Taylor JK, Singanayagam A, Fleming GB, Akram AR, Mandal P, Choudhury G, Hill AT (2011) Epidemiology, antibiotic therapy, and clinical outcomes in health care-associated pneumonia: a UK cohort study. Clin Infect Dis 53(2):107-113
32. Hsu JL, Siroka AM, Smith MW, Holodniy M, Meduri GU (2011) One-year outcomes of community-acquired and healthcare-associated pneumonia in the Veterans Affairs Healthcare System. Int J Infect Dis 15(6):e382-e387
33. Umeki K, Tokimatsu I, Yasuda C, Iwata A, Yoshioka D, Ishii H, Shirai R, Kishi K, Hiramatsu K, Matsumoto B, Kadota J (2011) Clinical features of healthcare-associated pneumonia (HCAP) in a Japanese community hospital: comparisons among nursing home-acquired pneumonia (NHAP), HCAP other than NHAP, and community-acquired pneumonia. Respirology 16(5):856-861
34. Kung J, Miller RR, Mackowiak PA (2012) Failure of clinical practice guidelines to meet Institute of Medicine standards: two more decades of little, if any, progress. Arch Intern Med 172:1628-1633
35. Graham R, Mancher M, Wolman D, Greenfield S, Steinberg E (2011) Clinical practice guidelines we can trust. The National Academies, Washington, DC
36. El-Solh AA, Peter M, Alfarah Z, Akinnusi ME, Alabbas A, Pineda LA (2010) Antibiotic prescription patterns in hospitalized patients with nursing home-acquired pneumonia. J Hosp Med 5(3):E5-E10
37. Rello J, Lujan M, Gallego M, Valles J, Belmonte Y, Fontanals D, Diaz E, Lisboa T, Group PS (2010) Why mortality is increased in health-care-associated pneumonia: lessons from pneumococcal bacteremic pneumonia. Chest 137(5):1138-1144
38. Polverino E, Dambrava P, Cilloniz C, Balasso V, Marcos MA, Esquinas C, Mensa J, Ewig S, Torres A (2010) Nursing home-acquired pneumonia: a 10 year single-centre experience. Thorax 65(4):354-359
39. Ewig S, Klapdor B, Pletz MW, Rohde G, Schutte H, Schaberg T, Bauer TT, Welte T, CAPNETZ Study Group (2012) Nursing-home-acquired pneumonia in Germany: an 8-year prospective multicentre study. Thorax 67(2):132-138
40. Kawasaki S, Aoki N, Kikuchi H, Nakayama H, Saito N, Shimada H, Miyazaki S, Sakai S, Suzuki M, Narita I (2011) Clinical and microbiological evaluation of hemodialysis-associated pneumonia (HDAP): should HDAP be included in healthcare-associated pneumonia? J Infect Chemother 17(5):640-645
41. Viasus D, Garcia-Vidal C, Cruzado JM, Adamuz J, Verdaguer R, Manresa F, Dorca J, Gudiol F, Carratala J (2011) Epidemiology, clinical features and outcomes of pneumonia in patients with chronic kidney disease. Nephrol Dial Transplant 26(9):2899-2906
42. Brito V, Niederman MS (2009) Healthcare-associated pneumonia is a heterogeneous disease, and all patients do not need the same broad-spectrum antibiotic therapy as complex nosocomial pneumonia. Curr Opin Infect Dis 22(3):316-325